This treatment dramatically increases inducible NO synthase (iNOS/NOS2) activity, thus NO, resulting in a synergistic effect of resistance to cell death pathways (primarily apoptosis) while simultaneously promoting tumor growth, migration, and invasiveness [108,109]. Here, NOS2 is linked to neoplasm.